The Republicans argued that FDA approval of a drug does not give the manufacturer an unconditional right to the sell the medication at all times.

To combat her own health issues, Catherine Perez switched careers and became a vegan dietitian. Now, she lives a healthier lifestyle and makes $125,000 a year.

Retirement 401(k) account balances lost nearly one-quarter of their value in 2022, but there is still the potential for a comeback this year, one expert says.

Goldman Sachs highlights several opportunities for investors to play an uncertain environment now that the fourth quarter earnings season is over.

Oxy CEO Vicki Hollub shows just how much oil companies are worried about political blowback related gas prices and stock buybacks. Not much. Maybe not at all.

Baird initiated coverage of bluebird bio with an outperform rating and $10 price target, which implies 104% upside from Monday’s close.

Since Howard Schultz returned to the helm of the company in April last year, Starbucks has taken a more aggressive approach to oppose a union push.

After keeping our powder dry since the end of February, we’re making one small buy into weakness Tuesday.

Airlines rose, while Rivian shares were under pressure.

If you haven’t filed your 2022 taxes yet, you may qualify for one of the free filing options. Here’s what taxpayers need to know.